4//SEC Filing
DRACHMAN JONATHAN G 4
Accession 0001209191-22-039325
CIK 0001708493other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:45 PM ET
Size
5.4 KB
Accession
0001209191-22-039325
Insider Transaction Report
Form 4
DRACHMAN JONATHAN G
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 totalExercise: $2.01Exp: 2032-06-21→ Common Stock (10,167 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001588467
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:45 PM ET
- Size
- 5.4 KB